1. Peptide structure and analysis / Carlo Pedone. [et al.] -- 2. Radiopeptide targeting for tumor therapy : peptide receptor distribution / Jean Claude Reubi -- 3. Developments of radiolabeled peptides / Ronald E. Weiner and Mathew L. Thakur -- 4. The labeling of peptides with positron-emitting radionuclides : the importance of PET in cancer diagnosis / Stefano Papi. [et al.] -- 5. Radiolabeling DOTA-peptides with [superscript 90]Y and [superscript 177]Lu to a high specific activity / Wouter A. P. Breeman. [et al.] -- 6. Peptide receptor radionuclide therapy : preclinical findings / Astrid Capello. [et al.] -- 7. Pathological evaluation and biochemical characterization of peptide receptors other than somatostatin receptors as potential tumor targets for radionuclide diagnosis and therapy / Giuseppe Pelosi, Michele Masullo, and Giuseppe Viale -- 8. Peptide Receptor Therapy with [superscript 90]Y-dotatoc : the emerging experience in Chile / Horacio Amaral -- 9. Therapeutic potential of radiolabeled peptides : the basel experience / Christian Waldherr and Jan Muller-Brand -- 10. Somatostatin receptor-mediated radionuclide therapy forcancer : therapy with [superscript 90]Y-DOTA-lanreotide / Irene Virgolini. [et al.] -- 11. Receptor radionuclide therapy with [superscript 90]Y-[DOTA[superscript 0]]-Tyr[superscript 3]- octreotide ([superscript 90]Y-DOTATOC) : the IEO experience / Lisa Bodei and Giovanni Paganelli --

12. New clinical studies with [superscript 177]Lu-labelled somatostatin analogs / Dik J. Kwekkeboom and Eric P. Krenning -- 13. Radiation dosimetry methods for therapy / Michael G. Stabin -- 14. Dosimetry applied to peptide radionuclide receptor therapy / Marta Cremonesi -- 15. Methods to reduce radiation exposure to personnel during radiolabelling and infusion / Mahila Ferrari -- 16. Regulatory requirements for therapy trials / Giampiero Tosi -- 17. Pretargeted peptide delivery with irreversible antibody / David A. Goodwin and Claude F. Meares -- 18. Targeted chemotherapy : new approaches to treatment of various cancers based on cytotoxic analogs of luteinizing hormone-releasing hormone (LH-RH), somatostatin and bombesin / Andrew V. Schally, Attila Nagy, and Ana Maria Comaru-Schally.